Wealthspring Capital’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Wealthspring Capital’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-359,250	Closed	-$3.69M	–	107
2023 Q2	$3.69M	Buy	359,250 +294,625	+456%	+$3.01M	5.12%	5
2023 Q1	$654K	Buy	64,625 +27,125	+72%	+$273K	1.07%	30
2022 Q4	$371K	Buy	+37,500	New	+$369K	0.56%	59

Wealthspring Capital's DALS Position: Q3 2023 in Review

Wealthspring Capital sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 359,250 shares — an estimated $3.69M sold.

Wealthspring Capital first reported a position in DALS in Q4 2022 and held it in 3 quarters. The position peaked at $3.69M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Wealthspring Capital reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Wealthspring Capital sold 359,250 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $3.69M.
Wealthspring Capital first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 3 quarters.
Wealthspring Capital's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $3.69M in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Wealthspring Capital's 13F filing for Q3 2023, filed 19 Oct 2023.